Brief: Galenica Confirms 2025 Guidance
May 22 (Reuters) - GALENICA AG GALE.S: CONTINUES SALES GROWTH CONFIRMS 2025 GUIDANCE WITH SALES GROWTH OF 3-5% AND EBIT GROWTH OF 4-6% GALENICA AG - SALES GROWTH OF 4.7% TO CHF 1,314.2 MILLION IN JAN-APRIL Source text: ID:nEQBcgZ2a Further company coverage: GALE.S (Gdansk Newsroom) ((gdansk.newsroom@thomsonreuters.com; +48 58 769 66 00;))
Recent news on Galenica AG
See all newsBrief: Galenica Successfully Places A Bond Of Over CHF 200 Million
Swiss stocks - Factors to watch on October 22
Brief: Galenica Sales Up 5.7% To CHF 3.17 Bln In First Nine Months Of 2026, Confirms Outlook
Swiss stocks - Factors to watch on September 2
Switzerland's Galenica H1 sales rise on pharmacy services demand